Google Mail Calendar Documents Reader Web more »
Help | Sign in
Go to Google Groups Home
   
Discussions for Genentech, Inc. View all discussions
My starred discussions
My profile

  Avastin Colon Cancer Results & Roche's $95/sh price
Only 1 message in discussion  - 
Reporting discussion
Messages reported
The group you are posting to is a Usenet group. Messages posted to this group will make your email address visible to anyone on the Internet.
Your reply message has not been sent.
Your post was successful
 
From:
To:
Cc:
Follow-up To:
Add Cc | Add Follow-up to | Edit Subject
Subject:
Validation:
For verification purposes please type the characters you see in the picture below or the numbers you hear by clicking the accessibility icon. Listen and type the numbers that you hear
 
spender...@gmail.com  
View profile   Translate to Translated (View Original)
 More options 23 Mar, 20:57
From: spender...@gmail.com
Date: Mon, 23 Mar 2009 13:57:40 -0700 (PDT)
Local: Mon 23 Mar 2009 20:57
Subject: Avastin Colon Cancer Results & Roche's $95/sh price
Reply to author | Forward | Print | Individual message | Report this message | Find messages by this author
If you bought DNA today for ~$94/share, and held on to it for the
results of the Avastin Colon Cancer study (scheduled sometime end of
March), could you get the upside - ~$110/sh, without the downside risk
(~75/sh), by selling off the shares at the Roche price on 4-15-2009 if
the study was bad?  Or will the price of DNA, never go above $95/sh,
even if the Avastin Colon Cancer study shows good results?

Thanks for your opinions


    Reply to author    Forward  
You must Sign in before you can post messages.
To post a message, you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.

End of messages  

« Newer discussion  -  DNA LEAP options   Anybody work for Genentech??  -  Older discussion »




Google Home - Terms of Service - Privacy Policy

©2009 Google